Metoprolol Tartrate Compounded Oral Suspension
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Metoprolol Tartrate Compounded Oral Suspension contains NLT 90.0% and NMT 110.0% of the labeled amount of metoprolol tartrate [(C15H25NO3)2 · C4H6O6]
Prepare Metoprolol Tartrate Compounded Oral Suspension 10 mg/mL as follows (see Pharmaceutical Compounding-Nonsterile Preparations (795)).
| Metoprolol Tartrate | 1 g |
| Vehicle: a 1:1 mixture of Vehicle for Oral Solution, (regular or sugar-free), NF, and Vehicle for Oral Suspension, NF, a sufficient quantity to make | 100 mL |
Place the required number of tablets in a suitable mortar, and comminute to a fine powder, or use Metoprolol Tartrate powder. Add the Vehicle in small portions, and mix well. Transfer the contents of the mortar, stepwise and quantitatively, to a calibrated bottle. Add the Vehicle in portions to rinse the mortar. Add sufficient Vehicle to bring to final volume, and mix well.
2 ASSAY
PROCEDURE
Mobile phase: 961 mg of 1-pentanesulfonic acid sodium salt (monohydrate) and 82 mg of anhydrous sodium acetate in a mixture of 550 mL of methanol and 470 mL of water. Add 0.57 mL of glacial acetic acid. Filter, and degas.
Standard solution: 100 µg/mL of USP Metoprolol Tartrate RS
Sample solution: Agitate the container of Oral Suspension for 30 min on a rotating mixer, remove a 5-mL sample, and store in a clear glass vial at-70 until analyzed. At the time of analysis, remove the sample from the freezer, allow it to reach room temperature, and mix with a vortex mixer for 30 s. Pipet 1.0 mL of the sample to a 100-mL volumetric flask, and dilute with Mobile phase to volume.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm x 25-cm; 5-µm packing L1
Flow rate: 1.0 mL/min
Injection volume: 20 µL
System suitability
Sample: Standard solution
[NOTE-The retention time for metoprolol tartrate is about 7.3 min.]
Suitability requirements
Relative standard deviation: NMT 1.3% for replicate injections
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of metoprolol tartrate [(C15H25NO3)2 · C4H6O6] in the portion of Oral Suspension taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Metoprolol Tartrate RS in the Standard solution (µg/mL)
CU = nominal concentration of metoprolol tartrate in the Sample solution (µg/mL)
Acceptance criteria: 90.0%-110.0%
3 SPECIFIC TESTS
PH (791): 3.6-4.6
4 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Package in tight, light-resistant containers. Store at controlled room temperature, or in a refrigerator.
BEYOND-USE DATE: NMT 60 days after the date on which it was compounded when stored at controlled room temperature, or in a refrigerator
LABELING: Label it to state that it is to be well shaken, and to state the Beyond-Use Date.
USP REFERENCE STANDARDS (11)
USP Metoprolol Tartrate RS

